Icatibant
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Icatibant is a prescription injectable medication used to treat acute hereditary angioedema attacks. It works as a bradykinin B2 receptor antagonist and is administered subcutaneously as a 30 mg dose in 3 mL of solution. Manufactured by Eugia US LLC. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Icatibant
Access the FDA dataset for Icatibant β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025